Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom
Level 5 - mechanism / opinion, no new human data
Narrative review and expert commentary without systematic review methods or original human data.
OpenAlex W3120234758 · doi:10.1172/jci142246
What was done
This is a narrative commentary summarizing the historical context, physiological rationale, and preliminary evidence for dietary carbohydrate restriction in managing type 1 and type 2 diabetes.
What was found
The abstract reports no numerical data. It qualitatively notes that low-carbohydrate diets show preliminary benefits for body weight, postprandial hyperglycemia, hyperinsulinemia, and other cardiometabolic risk factors in type 2 diabetes, with more limited evidence in type 1 diabetes.
Why it matters
It highlights dietary carbohydrate restriction as a potentially low-cost intervention to help achieve clinical glycemic targets when conventional pharmacological approaches fail to eliminate vascular complication risks.
Limits
This is an expert narrative review rather than an empirical study or systematic review; no original data, sample size, or quantitative risk estimates are provided, and long-term safety data are noted as lacking.
Cited by
- supports Carbohydrate restriction was used at the Joslin clinic in the 1900s and early 1920s to treat type 1 diabetes before insulin was developed.